In addition, apigenin inhibited the growth of MDA-MB-231 breast cancer xenografts accompanied by reduced levels of IL-6, pSTAT3, pERK, PI3K, pAkt, and N-cadherin. This evidence concerns the gene IL6 and breast carcinoma.